SOX2 and cancer: Accumulating evidence has shown that STAT3 activation plays an important role in the growth and maintenance of GSCs by increasing the expression of major cancer stemness markers, including CD133, Sox2, Oct4, Nanog, ALDH1A1, and integrin α6 [23,24].